Patent Assignment
Reel/Frame 024633/0976
Assignment of Assignor's Interest
Recorded: 2010-07-02
Pages: 2
Assignor
HARIRI, ROBERT J.
Executed: 2004-07-16
Assignee
ANTHROGENESIS CORPORATION
7 POWDER HORN DRIVE, WARREN, NEW JERSEY, 07059
Covered Property
(1)
Use of umbilical cord blood to treat individuals having a disease, disorder or condition
Application:
11/593,348 →
Publication:
US 2007/0053888
Related Assignments
(5)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Aug 11, 2016
From: ANTHROGENESIS CORPORATION, A NEW JERSEY CORPORATION, D/B/A CELGENE CELLULAR THERAPEUTICS
To: HLI CELLULAR THERAPEUTICS, LLC, A DELAWARE LIMITED LIABILITY COMPANY
Reel/Frame 039411/0443 →
Merger
Nov 8, 2017
From: ANTHROGENESIS CORPORATION
To: CLARITY ACQUISITION II LLC
Reel/Frame 044413/0680 →
Change of Name
Nov 9, 2017
From: HLI CELLULAR THERAPEUTICS, LLC
To: CELULARITY BIOSOURCING, LLC
Reel/Frame 044707/0351 →
Assignment of Assignor's Interest
Nov 9, 2017
From: CLARITY ACQUISITION II LLC
To: CELULARITY, INC.
Reel/Frame 044780/0261 →
Assignment of Assignor's Interest
Nov 11, 2017
From: CELULARITY BIOSOURCING, LLC
To: CELULARITY, INC.
Reel/Frame 044098/0717 →